Octapeptin is a peptide antibiotic which affects bacterial membrane structure and selective membrane permeability for protons and potassium.
The octapeptins are a closely related class of peptide antibiotics1) which exhibit a broad range of antimicrobial activity against Gram-positive and Gram-negative bacteria2). The octapeptins are structurally related to the polymyxins and are characterized by a cyclic octapeptide containing a C: 10 or C: 11 fl-hydroxy fatty acid attached to the peptide through an amide bond3, 4, 5) .
A number of biochemical processes in bacteria are affected by octapeptins but mechanistic studies have strongly implicated the bacterial membrane as the primary site of actions'. Previous studies have indicated that the effects of octapeptin on bacterial metabolism are similar to those of uncouplers of oxidative phosphorylation7). The antibiotic stimulated bacterial respiration at concentrations corresponding to minimum inhibitory concentrations. It also enhanced the membrane proton permeability and lowered the adenosine 5'-triphosphate pool size. It was proposed that octapeptins disrupt the selective ion permeability of the cytoplasmic membrane, thereby relaxing the membrane potential. In the present study, this hypothesis was directly tested by examining the influence of octapeptin on the membrane potential in E. coli membrane vesicles. It is demonstrated that octapeptin inhibits both formation of the membrane potential generated in the presence of respiratory substrates and respiratory coupled leucine transport. Methods Growth of Bacteria and Preparation of Vesicles Escherlclria coli strain ML-308-225 was grown on Minimal Medium A8)containing 1%sodium succinate as a carbon source and a trace of FeSO4 • 7H2O (0.00005%). Membrane vesicles were prepared as described9), and 1 ml aliquots were frozen and stored in liquid N2at 4.5 mg protein/ml in 100 mM potassium phosphate at pH 6.6.
Materials and Methods

Materials
Transport Assays
In all cases, frozen vesicles were thawed rapidly at 46°C. For [3H3]-leu transport assays, the vesicles were diluted to 1 mg protein/ml in 100 mM potassium phosphate, pH 6.6, incubated at 25°C for 20 minutes and stored on ice until assayed. All transport assays were done in buffers containing no Mg2+ since it inhibits the antimicrobial activity of octapeptin11). Mg2+ is not required for the coupling of respiration to either leu transport or valinomycin facilitated Rb+ transport. For 86Rb+ uptake , the vesicles were treated as previously described10)using 100 mm sodium phosphate, pH 6.6, throughout. Final suspensions were in the same buffer at 1 mg protein/mi. Valinomycin was added (2 nmoles/mg protein) and the vesicles were then stored on ice until assayed.
All assays were performed at 25°C in 13 x 100 mm test tubes using an apparatus previously described10)with O2 used to aerate the samples. All radiolabelled substrates, electron donors, inhibitors, and antibiotics were added (0.5~1.0 tit) to 100 /it aliquots of the vesicles at the concentrations indicated using Hamilton syringes. Following removal from the ice, the vesicles were incubated for 3 minutes prior to addition of the electron donor and the radiolabelled substrate. Unless indicated otherwise, all antibiotics or inhibitors were added 1 minute prior to the addition of electron donors.
Uptake of either [3H3]-leu or 86Rb+ was determined by rapid filtration on cellulose triacetate filters (0.45 lc) using 100 mm LiCl throughout to dilute and wash the samples. With the exception of the release studies, all time points represent the time between addition of the radiolabelled substrate and dilution with 100 mM LiCl. Filters were thoroughly dried and allowed to completely dissolve in scintillation fluid before counting. Each data point was corrected for nonspecific binding of radioactively labelled ligands using controls which were treated identically in the absence of an electron dolor.
Calculations of intravesicular concentrations of either [3H3]-leu or 86Rb+ assumed a value of 2.2 linternal volume/mg protein12). Membrane potentials determined from 86Rb+ uptake experiments were calculated using the NERNST equation; di,'i=58. Protein was determined by the method of LOWRY13).
Results
Influence of Octapeptin on Formation of the Membrane Potential
A number of radiolabelled ions have been used to monitor formation of the electrical potential generated by respiration in bacterial membrane vesicles14~18). These include the lipophilic cations dimethyl dibenzyl ammonium and triphenyl methyl phosphonium as well as 86Rb+ (with valinomycin).
Initial experiments indicated that octapeptin interacted quite strongly with the lipophilic cations, but not with 86Rb+ and valinomycin. Therefore, the 86Rb+-valinomycin transport system18)was used to measure the formation of a membrane potential in the presence or absence of octapeptin. The influence of octapeptin on the formation of the membrane potential by E. coli vesicles is presented in Fig. 1 . Membrane potentials were established using either succinate (Fig. 1A) or Asc/ PMS (Fig. 1B) as electron donors. In the absence of octapeptin, a membrane potential was rapidly generated using either respiratory substrate, although the rate and extent of membrane potential formation was lower with succinate compared to Asc/PMS. The maximum membrane potentials formed in the presence of succinate and Asc/PMS were 59 and 66 mV respectively. Formation of the membrane potential generated in the presence of either succinate or Asc/PMS was markedly inhibited by octapeptin (Fig. 1) . For example, the maximum Asc/PMS generated membrane potentials were 66, 62, 44 and 25 mV in the presence of 0, 10, 50 and 100/uM octapeptin, respectively. Complete inhibition of membrane potential formation was achieved at 200,uM octapeptin (not shown). The effects of octapeptin on 86Rb+ uptake were compared to CCCP since CCCP is a proton conductor which effectively collapses the electrical potential across bacterial membrane systems17).
The influence of CCCP on membrane potentials generated in the presence of succinate or Asc/PMS was qualitatively similar to octapeptin (Fig. 2) . CCCP inhibited both the rate and extent of membrane potential formation. However, CCCP was clearly more effective than octapeptin since comparable effects required 20~50-times higher octapeptin concentrations.
Influence of Octapeptin on Leucine Transport
The data discussed above illustrated that octapeptin inhibited the formation of the membrane potential in the presence of appropriate electron donors. Therefore, one would expect the antibiotic to inhibit active transport of metabolites which are driven by the membrane potential14,17,19,20)
Fig. 3 illustrates that KABACK vesicles accumulated [3H]-leucine against a concentration gradient in
the presence of succinate (Fig. 3A) or Asc/PMS (Fig. 3B) . Succinate driven accumulation of [3H]-leucine was less effective than Asc/PMS.
Octapeptin inhibited leucine transport driven by either respiratory substrate (Fig. 3) . Inhibition of leucine transport by octapeptin varied as a function of the peptide concentration. For example, Asc/PMS driven leucine transport was inhibited 25%, 66% and 100%. at octapeptin concentrations of 10, 50 and 100 /CM (Fig. 3B) . By comparison, membrane potential formation was inhibited 38 %, 82% and 94%at octapeptin concentrations of 10, 50 and 100 /GM (Fig. 1B) . A similar correlation was observed between octapeptin inhibition of membrane potential formation and leucine transport when succinate served as the electron donor (Fig. 1A and Fig. 3A ). These observations strongly suggest that octapeptin inhibition of leucine transport is due to direct effects of the peptide on the membrane potential. 
Inhibition of Leucine Transport by CCCP
The data discussed so far have shown that octapeptin is effective in inhibiting both the gene- Membrane vesicles were at a concentration of 1 mg membrane protein/ ml. Sodium succinate, sodium ascorbate, PMS and [3H]-leucine were at concentrations of 20 mM, 20 mM, 100 ffM and 500 ,uM, respectively.
[3H]-leucine uptake was monitored as described in Methods. On the basis of these observations, it was proposed that the primary action of octapeptin is to increase the membrane permeability for small ions and relax the membrane potential6,7). This proposal is supported by the data presented in this study . Octapeptin inhibited ormation of the membrane potential generated in the presence of either succinate or Asc/PMS.
The antibiotic also inhibited leucine transport which is clearly coupled to the bacterial membrane potential.
The molecular mechanism underlying octapeptin's effects on membrane permeability is not establishec. However, the peptide probably does not function as a proton ionophore since it bears a net positive charge of four at physiological pH and relatively high densities of bound antibiotic were required to inhibit bacterial growth and formation of the membrane potential.
Furthermore , previous studies using octapeptin covalently attached to agarose beads illustrated that the antibiotic can affect the permeability and respiration of spheroplasts and protoplasts by interacting with the outside surface of vesicles21). It has been proposed that octapeptin interacts electrostatically with membrane lipid phosphates with insertion of the fatty acid tail into the center of the membrane. These interactions may cause disruption of membrane lipid packing and surface charge and lead to increased small ion permeability.
This hypothetical model can account for all of the biochemical effects of octapeptin and is most consistent with the available data. 
